These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9629529)

  • 1. Effects of trihexyphenidyl on MMSE and CAMCOG scores of medicated elderly patients with schizophrenia.
    Heinik J
    Int Psychogeriatr; 1998 Mar; 10(1):103-8. PubMed ID: 9629529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric profiling of the elderly using the Cambridge Cognitive Examination.
    Johnston B; Scott N; Li Wan Po A; Jack DB
    Ann Pharmacother; 1995 Oct; 29(10):982-7. PubMed ID: 8845558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
    Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
    Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brief cognitive evaluation and diagnosis of dementia, depression, and psychosis in the elderly].
    Reys BN; Bezerra AB; Vilela AL; Keusen AL; Marinho V; Paula Ed; Laks J
    Rev Assoc Med Bras (1992); 2006; 52(6):401-4. PubMed ID: 17242775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of anticholinergic medication on memory in schizophrenia.
    Strauss ME; Reynolds KS; Jayaram G; Tune LE
    Schizophr Res; 1990; 3(2):127-9. PubMed ID: 1980611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Mini-Mental State Examination (MMSE) in long-stay patients with schizophrenia or schizoaffective disorders in a psychiatric institute.
    Ong HL; Subramaniam M; Abdin E; Wang P; Vaingankar JA; Lee SP; Shafie S; Seow E; Chong SA
    Psychiatry Res; 2016 Jul; 241():256-62. PubMed ID: 27203153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients.
    Drimer T; Shahal B; Barak Y
    Int Clin Psychopharmacol; 2004 Jan; 19(1):27-9. PubMed ID: 15101567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mental slowing associated with the APOE epsilon4 allele after trihexyphenidyl oral anticholinergic challenge in healthy elderly.
    Pomara N; Belzer K; Hernando R; De La Pena C; Sidtis JJ
    Am J Geriatr Psychiatry; 2008 Feb; 16(2):116-24. PubMed ID: 18239197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clock drawing test in elderly schizophrenia patients.
    Heinik J; Vainer-Benaiah Z; Lahav D; Drummer D
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):653-5. PubMed ID: 9215948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
    Manos N; Gkiouzepas J; Logothetis J
    Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of dementia in the elderly. A comparison of CAMCOG (the cognitive section of CAMDEX), the AGECAT program, DSM-III, the Mini-Mental State Examination and some short rating scales.
    Blessed G; Black SE; Butler T; Kay DW
    Br J Psychiatry; 1991 Aug; 159():193-8. PubMed ID: 1773235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia.
    Goff DC; Amico E; Dreyfuss D; Ciraulo D
    Am J Psychiatry; 1994 Mar; 151(3):429-31. PubMed ID: 8109654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between medication treatments and neuropsychological test performance in schizophrenia.
    Sweeney JA; Keilp JG; Haas GL; Hill J; Weiden PJ
    Psychiatry Res; 1991 Jun; 37(3):297-308. PubMed ID: 1679950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gradual withdrawal of long-term anticholinergic antiparkinson medication in Chinese patients with chronic schizophrenia.
    Ungvari GS; Chiu HF; Lam LC; Pang AH; Chung DW; Li SW; Chiu SN; Lum FC; Leung T
    J Clin Psychopharmacol; 1999 Apr; 19(2):141-8. PubMed ID: 10211915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample.
    Huppert FA; Brayne C; Gill C; Paykel ES; Beardsall L
    Br J Clin Psychol; 1995 Nov; 34(4):529-41. PubMed ID: 8563660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.
    Budge MM; de Jager C; Hogervorst E; Smith AD;
    J Am Geriatr Soc; 2002 Dec; 50(12):2014-8. PubMed ID: 12473014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CAMCOG: a useful screening instrument for dementia in stroke patients.
    de Koning I; van Kooten F; Dippel DW; van Harskamp F; Grobbee DE; Kluft C; Koudstaal PJ
    Stroke; 1998 Oct; 29(10):2080-6. PubMed ID: 9756586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.